Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

NCT05391867 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Lenvatinib

Sponsor

Sir Salimullah Medical College Mitford Hospital